Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review
Takeda Pharmaceutical Company Limited (4502) - Financial and Strategic SWOT Analysis Review
Summary
Takeda Pharmaceutical Company Limited (Takeda) is a Japan-based pharmaceutical company. The company is involved in the manufacture of ethical drugs and consumer health care products. The company manufactures and markets photographic chemicals, inorganic chemicals, vitamin bulks, test reagents and clinical diagnostics. Takeda markets its ethical drugs in over 100 countries world wide through its subsidiaries in North America, Europe and Asia. The company has production facilities in Osaka, Hikari, Italy, Ireland, China and Indonesia. It has R&D facilities in Palo Alto, San Diego, San Francisco, Deerfield (US), Osaka, Tsukuba (Japan), London, Cambridge(UK) and Singapore. Takeda is headquartered in Chuo-ku, Osaka, Japan.
Takeda Pharmaceutical Company Limited Key Recent Developments
May 01, 2012: R-Tech Ueno Provides Update On Anticipated Date Of Arbitration Decision Against Takeda
Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective Drug Research
Mar 29, 2012: Takeda To Establish New Global Headquarters Structure To Effectively Align With Expanded Global Operations
Feb 09, 2012: Takeda Establishes Development Center In China
Feb 01, 2012: Takeda Reports Net Sales Of JPY1.13 Trillion For Nine Months Ended December 31, 2011
This comprehensive SWOT profile of Takeda Pharmaceutical Company Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
Summary
Takeda Pharmaceutical Company Limited (Takeda) is a Japan-based pharmaceutical company. The company is involved in the manufacture of ethical drugs and consumer health care products. The company manufactures and markets photographic chemicals, inorganic chemicals, vitamin bulks, test reagents and clinical diagnostics. Takeda markets its ethical drugs in over 100 countries world wide through its subsidiaries in North America, Europe and Asia. The company has production facilities in Osaka, Hikari, Italy, Ireland, China and Indonesia. It has R&D facilities in Palo Alto, San Diego, San Francisco, Deerfield (US), Osaka, Tsukuba (Japan), London, Cambridge(UK) and Singapore. Takeda is headquartered in Chuo-ku, Osaka, Japan.
Takeda Pharmaceutical Company Limited Key Recent Developments
May 01, 2012: R-Tech Ueno Provides Update On Anticipated Date Of Arbitration Decision Against Takeda
Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective Drug Research
Mar 29, 2012: Takeda To Establish New Global Headquarters Structure To Effectively Align With Expanded Global Operations
Feb 09, 2012: Takeda Establishes Development Center In China
Feb 01, 2012: Takeda Reports Net Sales Of JPY1.13 Trillion For Nine Months Ended December 31, 2011
This comprehensive SWOT profile of Takeda Pharmaceutical Company Limited provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description - A detailed description of the company’s operations and business divisions.
- Corporate strategy - Analyst’s summarization of the company’s business strategy.
- SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives’ employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities - A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Note: Some sections may be missing if data is unavailable for the company.
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Contents
SECTION 1 - ABOUT THE COMPANYTakeda Pharmaceutical Company Limited - Key Facts
Takeda Pharmaceutical Company Limited - Key Employees
Takeda Pharmaceutical Company Limited - Key Employee Biographies
Takeda Pharmaceutical Company Limited - Major Products and Services
Takeda Pharmaceutical Company Limited - Pharmaceutical Pipeline Products Data
Takeda Pharmaceutical Company Limited, Pipeline Products by Therapy Area
Takeda Pharmaceutical Company Limited, Pipeline Products by Development Phase
Takeda Pharmaceutical Company Limited - History
Takeda Pharmaceutical Company Limited - Company Statement
Takeda Pharmaceutical Company Limited - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Takeda Pharmaceutical Company Limited - Key Manufacturing Facilities
SECTION 2 – COMPANY ANALYSIS
Takeda Pharmaceutical Company Limited - Business Description
Takeda Pharmaceutical Company Limited - Corporate Strategy
Takeda Pharmaceutical Company Limited - SWOT Analysis
SWOT Analysis - Overview
Takeda Pharmaceutical Company Limited - Strengths
Strength - Extensive Range of Products
Strength - Sturdy Research and Development Activities
Strength - Geographical Landscape
Strength - Focus on Partnerships and Collaboration
Takeda Pharmaceutical Company Limited - Weaknesses
Weakness - Weak Profitability Indicators
Weakness - Product Recalls & Discontinued Projects
Takeda Pharmaceutical Company Limited - Opportunities
Opportunity - Strategic Business Initiatives
Opportunity - Pipeline Products
Opportunity - Demographics Trends
Takeda Pharmaceutical Company Limited - Threats
Threat - Increased Scrutiny on Imports
Threat - Stringent Government Regulations
Threat - Uncertain R&D Outcomes
Threat - Competitive Landscape
Threat - Global Economic Scenario
Takeda Pharmaceutical Company Limited - Key Competitors
SECTION 3 – COMPANY FINANCIAL RATIOS
Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts
SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES
Takeda Pharmaceutical Company Limited, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Medical Equipment, Deals By Year, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Medical Equipment, Deals By Type, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Recent Deals Summary
SECTION 5 – COMPANY’S RECENT DEVELOPMENTS
Takeda Pharmaceutical Company Limited, Recent Developments
Apr 04, 2012: Takeda Joins Structural Genomics Consortium To Fund Collective Drug Research
Mar 29, 2012: Takeda To Establish New Global Headquarters Structure To Effectively Align With Expanded Global Operations
Feb 09, 2012: Takeda Establishes Development Center In China
Feb 01, 2012: Takeda Reports Net Sales Of JPY1.13 Trillion For Nine Months Ended December 31, 2011
Jan 18, 2012: Takeda Announces Strategic Measures To Achieve Efficiencies For Long-Term Growth
Jan 10, 2012: European Commission Adopts CHMP's Opinion Confirming Pioglitazone-Containing Medicines Remain Valid Treatment Option for Appropriate Type 2 Diabetes Patients
Jan 06, 2012: Takeda And Osaka University Establish Joint Research Chair To Develop Platform For Practical Application And Commercialization Of Nano-particle Vaccines
Dec 21, 2011: Takeda Integrates San Diego And San Francisco Subsidiaries To Establish Takeda California
Dec 21, 2011: Takeda Announces Changes In Management With Establishment Of New Organization
Dec 05, 2011: Takeda To Launch Global Vaccine Business
SECTION 6 – APPENDIX
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
LIST OF TABLES
Takeda Pharmaceutical Company Limited, Key Facts
Takeda Pharmaceutical Company Limited, Key Employees
Takeda Pharmaceutical Company Limited, Key Employee Biographies
Takeda Pharmaceutical Company Limited, Major Products and Services
Takeda Pharmaceutical Company Limited, Number of Pipeline Products by Therapy Area
Takeda Pharmaceutical Company Limited, Number of Pipeline Products by Development Stage
Takeda Pharmaceutical Company Limited, Pipeline Products By Therapy Area and Development Phase
Takeda Pharmaceutical Company Limited, History
Takeda Pharmaceutical Company Limited, Subsidiaries
Takeda Pharmaceutical Company Limited, Key Manufacturing Facilities
Takeda Pharmaceutical Company Limited, Key Competitors
Takeda Pharmaceutical Company Limited, Ratios based on current share price
Takeda Pharmaceutical Company Limited, Annual Ratios
Takeda Pharmaceutical Company Limited, Interim Ratios
Takeda Pharmaceutical Company Limited, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Pharmaceuticals & Healthcare, Deals By Type, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Medical Equipment, Deals By Year, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Medical Equipment, Deals By Type, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
LIST OF FIGURES
Takeda Pharmaceutical Company Limited, Pipeline Products by Therapy Area
Takeda Pharmaceutical Company Limited, Pipeline Products by Development Phase
Takeda Pharmaceutical Company Limited, Performance Chart (2007 - 2011)
Takeda Pharmaceutical Company Limited, Ratio Charts
Takeda Pharmaceutical Company Limited, Pharmaceuticals & Healthcare, Deals By Year, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Pharmaceuticals & Healthcare, Deals by Type, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Medical Equipment, Deals By Year, 2006 to YTD 2012
Takeda Pharmaceutical Company Limited, Medical Equipment, Deals by Type, 2006 to YTD 2012 Skip to top